{"nctId":"NCT00729469","briefTitle":"Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity","startDateStruct":{"date":"2008-07"},"conditions":["Atrophy","Vaginal Diseases"],"count":919,"armGroups":[{"label":"Ospemifene 60 mg/day and K-Y® lubricant","type":"EXPERIMENTAL","interventionNames":["Drug: Ospemifene 60 mg"]},{"label":"Placebo and K-Y® lubricant","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Ospemifene 60 mg","otherNames":["Osphena®"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Naturally or surgically menopausal\n* Moderate or severe symptoms of vaginal atrophy\n* 5% or fewer superficial cells in maturation index of vaginal smear\n* Vaginal pH greater than 5.0\n* Self reported Most Bothersome Symptom of vaginal dryness or vaginal pain associated with sexual activity, with a severity of moderate or severe at randomization\n\nExclusion Criteria:\n\n* Uterine bleeding of unknown origin, uterine polyps or symptomatic and/or large uterine fibroids\n* Current vaginal infection requiring medication\n* Clinically significant abnormal gynecological findings other than signs of vaginal atrophy (e.g.\n\nuterine or vaginal prolapse of Grade 2 or higher)\n\n* Previous participation in any other ospemifene study","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"40 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline to Week 12 in Percentage of Parabasal Cells in the Maturation Index of the Vaginal Smear (Dryness Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.7","spread":"29.97"},{"groupId":"OG001","value":"-31.7","spread":"37.25"}]}]}]},{"type":"PRIMARY","title":"Change From Baseline to Week 12 in Percentage of Superficial Cells in the Maturation Index of the Vaginal Smears (Dryness Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3","spread":"9.02"},{"groupId":"OG001","value":"12.4","spread":"15.36"}]}]}]},{"type":"PRIMARY","title":"Change From Baseline to Week 12 in Vaginal pH (Dryness Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.24","spread":"0.800"},{"groupId":"OG001","value":"-0.92","spread":"1.100"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Week 4 in Percentage of Parabasal Cells in the Maturation Index (Dryness Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.8","spread":"2.18"},{"groupId":"OG001","value":"-31.2","spread":"2.15"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Week 4 in Percentage of Superficial Cells in the Maturation Index (Dryness Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.6","spread":"1.07"},{"groupId":"OG001","value":"12.7","spread":"1.05"}]}]}]},{"type":"PRIMARY","title":"Change From Baseline to Week 12 in Severity of the Most Bothersome Symptom of Vaginal Dryness Associated With Sexual Activity (Dryness Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"23","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39","spread":null},{"groupId":"OG001","value":"51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"52","spread":null},{"groupId":"OG001","value":"39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"44","spread":null},{"groupId":"OG001","value":"44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"PRIMARY","title":"Change From Baseline to Week 12 in Percentage of Parabasal Cells in the Maturation Index of the Vaginal Smear (Dyspareunia Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"30.00"},{"groupId":"OG001","value":"-40.2","spread":"38.80"}]}]}]},{"type":"PRIMARY","title":"Change From Baseline to Week 12 in Percentage of Superficial Cells in the Maturation Index of the Vaginal Smears (Dyspareunia Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":"6.88"},{"groupId":"OG001","value":"12.3","spread":"14.77"}]}]}]},{"type":"PRIMARY","title":"Change From Baseline to Week 12 in Vaginal pH (Dyspareunia Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.07","spread":"0.814"},{"groupId":"OG001","value":"-0.94","spread":"1.016"}]}]}]},{"type":"PRIMARY","title":"Change From Baseline to Week 12 in Severity of the Most Bothersome Symptom of Vaginal Pain Associated With Sexual Activity (Dyspareunia Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47","spread":null},{"groupId":"OG001","value":"67","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70","spread":null},{"groupId":"OG001","value":"93","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76","spread":null},{"groupId":"OG001","value":"82","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"102","spread":null},{"groupId":"OG001","value":"55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Week 4 in Vaginal pH (Dryness Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.21","spread":"0.884"},{"groupId":"OG001","value":"-0.81","spread":"0.962"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Week 4 in Severity of Most Bothersome Symptom of Vaginal Dryness Associated With Sexual Activity (Dryness Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"31","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57","spread":null},{"groupId":"OG001","value":"67","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"60","spread":null},{"groupId":"OG001","value":"40","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Week 4 in Vaginal pH (Dyspareunia Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.15","spread":"0.821"},{"groupId":"OG001","value":"-0.82","spread":"0.979"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Week 4 in Severity of Most Bothersome Symptom of Vaginal Pain Associated With Sexual Activity (Dyspareunia Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"34","spread":null},{"groupId":"OG001","value":"39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"64","spread":null},{"groupId":"OG001","value":"72","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"84","spread":null},{"groupId":"OG001","value":"97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"95","spread":null},{"groupId":"OG001","value":"78","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"9","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Week 4 in Percentage of Parabasal Cells in the Maturation Index (Dyspareunia Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.8","spread":"1.59"},{"groupId":"OG001","value":"-37.8","spread":"1.54"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Week 4 in Percentage of Superficial Cells in the Maturation Index (Dyspareunia Strata)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":"0.69"},{"groupId":"OG001","value":"13.0","spread":"0.67"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":7,"n":456},"commonTop":["Urinary Tract Infection","Hot Flush","Headache","Nasopharyngitis","Upper Respiratory Tract Infection"]}}}